Connection

N'dri Kadiane-Oussou to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications N'dri Kadiane-Oussou has written about Antibodies, Monoclonal, Humanized.
N'dri Kadiane-Oussou
Connection Strength
0.105
Antibodies, Monoclonal, Humanized
  1. Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials. Rev Med Virol. 2022 01; 32(1):e2239.
    View in: PubMed
    Score: 0.048
  2. Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients. Int J Infect Dis. 2020 Oct; 99:491-495.
    View in: PubMed
    Score: 0.045
  3. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 02 11; 74(3):560-562.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.